RECURRENT CERVICAL CANCER
Clinical trials for RECURRENT CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CERVICAL CANCER trials appear
Sign up with your email to follow new studies for RECURRENT CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for cervical cancer: dual immunotherapy combo targets tumors after standard treatment fails
Disease control Not yet recruitingThis study is for women with cervical cancer that has come back or spread and no longer responds to standard immunotherapy. It tests a new combination of two immunotherapy drugs plus chemotherapy, with or without an anti-growth drug. The goal is to see if this combo can shrink tu…
Matched conditions: RECURRENT CERVICAL CANCER
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New hope for women with recurring cervical cancer: drug combo targets HER2-positive tumors
Disease control Not yet recruitingThis study tests a combination of three drugs (disitamab vedotin, iparomlimab, and tuvonralimab) in 33 women with HER2-expressing cervical cancer that has returned after first-line treatment. The goal is to see if the combination can shrink tumors or slow disease progression. Par…
Matched conditions: RECURRENT CERVICAL CANCER
Phase: PHASE2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated May 26, 2026 12:03 UTC